Chronic glucagon-like peptide-1 (GLP-1) increases survival in obese, hypertensive rats in association with increased cardiac mass, increased glucose uptake and reduced myocyte apoptosis

被引：0
|
作者：
Poornima, Indu G. [1 ]
Bhashyam, Siva [1 ]
Parikh, Pratik [1 ]
Bolukoglu, Hakki [1 ]
Shannon, Richard P. [1 ]
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1102
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [21] Glucagon-like peptide-1 (GLP-1) levels in obese patients with and without type 2 diabetes.
    Mannucci, E
    Ognibene, A
    Cremasco, F
    Bardini, G
    Mencucci, A
    Ciani, S
    Messeri, G
    Rotella, CM
    DIABETOLOGIA, 2000, 43 : A146 - A146
  • [22] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome
    Tzotzas, Themistoklis
    Karras, Spyridon N.
    Katsiki, Niki
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (03) : 218 - 229
  • [23] The role of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) in glucose-induced ileal brake in conscious rats
    Bozkurt, A
    Deniz, M
    Imeryuz, N
    Ulusoy, NB
    Yegen, BC
    GASTROENTEROLOGY, 2001, 120 (05) : A74 - A74
  • [24] In Vivo Suppression of Visfatin by Oral Glucose Uptake: Evidence for a Novel Incretin-Like Effect by Glucagon-Like Peptide-1 (GLP-1)
    Bala, Margarita
    Martin, Josefine
    Kopp, Andrea
    Hanses, Frank
    Buechler, Christa
    Schaeffler, Andreas
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (08): : 2493 - 2501
  • [25] Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)
    Yamato, E
    Ikegami, H
    Takekawa, K
    Fujisawa, T
    Nakagawa, Y
    Hamada, Y
    Ueda, H
    Ogihara, T
    HORMONE AND METABOLIC RESEARCH, 1997, 29 (02) : 56 - 59
  • [26] Effects of glucagon and glucagon-like peptide-1 (GLP-1) on glycemic status and glucose production in the isletectomized diabetic goby.
    Haigwood, JT
    Perez, M
    Kelley, KM
    AMERICAN ZOOLOGIST, 2000, 40 (06): : 1038 - 1039
  • [27] Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state
    Egan, JM
    Meneilly, GS
    Habener, JF
    Elahi, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3768 - 3773
  • [28] Effect of growth hormone on high plasma levels of glucagon-like peptide-1 (GLP-1) in hypophysectomized rats
    Tateishi, K
    Kitayama, N
    Ishikawa, H
    Mitsudome, A
    Hirose, S
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (07) : 361 - 363
  • [29] Comparison of the insulinotropic actions of exendin-4 and glucagon-like peptide-1 (GLP-1) during an intravenous glucose challenge in rats
    Parkes, D
    Jodka, L
    Smith, P
    Young, A
    DIABETES, 1999, 48 : A21 - A21
  • [30] The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling
    Dominguez Avila, J. Abraham
    Rodrigo Garcia, Joaquin
    Gonzalez Aguilar, Gustavo A.
    de la Rosa, Laura A.
    MOLECULES, 2017, 22 (06):
12345